Cargando…

Dynamic of plasmodium falciparum chloroquine resistance transporter gene Pfcrt K76T mutation five years after withdrawal of chloroquine in Burkina Faso

We investigated the evolution of Pfcrt K76T mutation five years after the withdrawal of chloroquine in Burkina Faso. A total of 675 clinical isolates collected from October 2010 to September 2012 were successfully genotyped. Single nucleotide polymorphism in Pfcrt (codon 76) gene was analyzed. The p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sondo, Paul, Derra, Karim, Tarnagda, Zekiba, Nakanabo, Seydou Diallo, Zampa, Odile, Kazienga, Adama, Valea, Innocent, Sorgho, Hermann, Ouedraogo, Jean-Bosco, Guiguemde, Tinga Robert, Tinto, Halidou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The African Field Epidemiology Network 2015
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606025/ https://www.ncbi.nlm.nih.gov/pubmed/26516402 http://dx.doi.org/10.11604/pamj.2015.21.101.6437

Ejemplares similares

Artesunate-Amodiaquine and Artemether-Lumefantrine Therapies and Selection of Pfcrt and Pfmdr1 Alleles in Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2016)

Effectiveness and safety of artemether–lumefantrine versus artesunate–amodiaquine for unsupervised treatment of uncomplicated falciparum malaria in patients of all age groups in Nanoro, Burkina Faso: a randomized open label trial
por: Sondo, Paul, et al.
Publicado: (2015)

Genetically diverse Plasmodium falciparum infections, within-host competition and symptomatic malaria in humans
por: Sondo, Paul, et al.
Publicado: (2019)

Polymorphisme de Plasmodium falciparum et mutations des gènes de résistance Pfcrt et Pfmdr1 dans la zone de Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2021)

Optimal Approach and Strategies to Strengthen Pharmacovigilance in Sub-Saharan Africa: A Cohort Study of Patients Treated with First-Line Artemisinin-Based Combination Therapies in the Nanoro Health and Demographic Surveillance System, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2020)

Determinants of Plasmodium falciparum multiplicity of infection and genetic diversity in Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2020)

Plasmodium falciparum gametocyte carriage in symptomatic patients shows significant association with genetically diverse infections, anaemia, and asexual stage density
por: Sondo, Paul, et al.
Publicado: (2021)

Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2022)

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study
por: Rouamba, Toussaint, et al.
Publicado: (2021)

Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change
por: Tinto, Halidou, et al.
Publicado: (2014)

Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania
por: Mohammed, Asia, et al.
Publicado: (2013)

Chloroquine sensitivity: diminished prevalence of chloroquine-resistant gene marker pfcrt-76 13 years after cessation of chloroquine use in Msambweni, Kenya
por: Kiarie, William Chege, et al.
Publicado: (2015)

Socioeconomic and environmental factors associated with malaria hotspots in the Nanoro demographic surveillance area, Burkina Faso
por: Rouamba, Toussaint, et al.
Publicado: (2019)

Reemergence of chloroquine-sensitive pfcrt K76 Plasmodium falciparum genotype in southeastern Cameroon
por: Ndam, Nicaise Tuikue, et al.
Publicado: (2017)

Assessment of the safety of antimalarial drug use during early pregnancy (ASAP): protocol for a multicenter prospective cohort study in Burkina Faso, Kenya and Mozambique
por: Tinto, Halidou, et al.
Publicado: (2015)

Use of proscribed chloroquine is associated with an increased risk of pfcrt T76 mutation in some parts of Ghana
por: Asare, Kwame K, et al.
Publicado: (2014)

The impact of clinical research activities on communities in rural Africa: the development of the Clinical Research Unit of Nanoro (CRUN) in Burkina Faso
por: Tinto, Halidou, et al.
Publicado: (2014)

An analysis of timing and frequency of malaria infection during pregnancy in relation to the risk of low birth weight, anaemia and perinatal mortality in Burkina Faso
por: Valea, Innocent, et al.
Publicado: (2012)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
por: Lingani, Moussa, et al.
Publicado: (2020)

Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso
por: Tahita, Marc C, et al.
Publicado: (2015)

Assessment of pfcrt 72-76 haplotypes eight years after chloroquine withdrawal in Kinshasa, Democratic Republic of Congo
por: Mvumbi, Dieudonné Makaba, et al.
Publicado: (2013)

Assessment of the Molecular Marker of Plasmodium falciparum Chloroquine Resistance (Pfcrt) in Senegal after Several Years of Chloroquine Withdrawal
por: Ndiaye, Magatte, et al.
Publicado: (2012)

Patterns of child mortality in rural area of Burkina Faso: evidence from the Nanoro health and demographic surveillance system (HDSS)
por: Noori, Navideh, et al.
Publicado: (2021)

Traitement préventif intermittent à la sulfadoxine – pyriméthamine du paludisme chez les femmes enceintes: efficacité et observance dans deux hôpitaux urbains du Burkina Faso
por: Bamba, Sanata, et al.
Publicado: (2013)

Population-based incidence, seasonality and serotype distribution of invasive salmonellosis among children in Nanoro, rural Burkina Faso
por: Guiraud, Issa, et al.
Publicado: (2017)

Baseline malarial and nutritional profile of children under seasonal malaria chemoprevention coverage in the health district of Nanoro, Burkina Faso
por: Sondo, Paul, et al.
Publicado: (2023)

The changing epidemiology of hepatitis B and C infections in Nanoro, rural Burkina Faso: a random sampling survey
por: Lingani, Moussa, et al.
Publicado: (2020)

High frequency of Plasmodium falciparum chloroquine resistance marker (pfcrt T76 mutation) in Yemen: An urgent need to re-examine malaria drug policy
por: Al-Mekhlafi, Abdulsalam M, et al.
Publicado: (2011)

Assessment of a combined strategy of seasonal malaria chemoprevention and supplementation with vitamin A, zinc and Plumpy’Doz™ to prevent malaria and malnutrition in children under 5 years old in Burkina Faso: a randomized open-label trial (SMC-NUT)
por: Sondo, Paul, et al.
Publicado: (2021)

Identification of a Mutant PfCRT-Mediated Chloroquine Tolerance Phenotype in Plasmodium falciparum
por: Valderramos, Stephanie G., et al.
Publicado: (2010)

Large-scale survey for novel genotypes of Plasmodium falciparum chloroquine-resistance gene pfcrt
por: Takahashi, Nobuyuki, et al.
Publicado: (2012)

Distribution of pfmdr1 and pfcrt chloroquine drug resistance alleles in north-western Nigeria
por: Muhammad, Ruqayyah H., et al.
Publicado: (2017)

Clinical management and mortality among COVID-19 cases in sub-Saharan Africa: A retrospective study from Burkina Faso and simulated case analysis
por: Skrip, Laura, et al.
Publicado: (2020)

Prevalence of the dhfr and dhps Mutations among Pregnant Women in Rural Burkina Faso Five Years after the Introduction of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine
por: Tahita, Marc C., et al.
Publicado: (2015)

Impact and operational feasibility of adding malaria infection screening using an ultrasensitive RDT for placental and fetal outcomes in an area of high IPTP-SP coverage in Burkina Faso: the ASSER MALARIA pilot study protocol
por: Tahita, Marc Christian, et al.
Publicado: (2022)

Chloroquine Clinical Failures in P. falciparum Malaria Are Associated with Mutant Pfmdr-1, Not Pfcrt in Madagascar
por: Andriantsoanirina, Valérie, et al.
Publicado: (2010)

Dynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum
por: Gadalla, Nahla B, et al.
Publicado: (2010)

The Knock-Down of the Chloroquine Resistance Transporter PfCRT Is Linked to Oligopeptide Handling in Plasmodium falciparum
por: Sanchez, Cecilia P., et al.
Publicado: (2022)

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
por: Gansané, Adama, et al.
Publicado: (2021)

Effects of maternal antenatal treatment with two doses of azithromycin added to monthly sulfadoxine-pyrimethamine for the prevention of low birth weight in Burkina Faso: an open-label randomized controlled trial
por: Lingani, Moussa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d6cobl983hhgjj1o2rgp9jcrsu